ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,414.99
-0.22%
Dow Jones
39,431.51
-0.21%
Gold vs US Dollar
2,345.695
0.28%
Brent Oil
83.275
0.08%
Bitcoin
62,640.60
-0.42%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Dermata Therapeutics Inc (DRMA)

  7. Dermata Therapeutics Inc (DRMA) News

Dermata Therapeutics (DRMA)

Dermata Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DRMA
DateTimeSourceHeadlineSymbolCompany
12/01/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRMADermata Therapeutics Inc
06/01/202402:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DRMADermata Therapeutics Inc
06/01/202402:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DRMADermata Therapeutics Inc
06/01/202402:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DRMADermata Therapeutics Inc
06/01/202402:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DRMADermata Therapeutics Inc
18/12/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DRMADermata Therapeutics Inc
15/12/202322:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:DRMADermata Therapeutics Inc
08/12/202322:29Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:DRMADermata Therapeutics Inc
07/12/202321:05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:DRMADermata Therapeutics Inc
29/11/202322:16Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:DRMADermata Therapeutics Inc
09/11/202321:09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DRMADermata Therapeutics Inc
09/11/202321:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRMADermata Therapeutics Inc
14/09/202321:32Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DRMADermata Therapeutics Inc
10/08/202321:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRMADermata Therapeutics Inc
10/08/202321:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DRMADermata Therapeutics Inc
03/08/202321:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRMADermata Therapeutics Inc
28/07/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DRMADermata Therapeutics Inc
27/07/202321:50Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:DRMADermata Therapeutics Inc
12/07/202314:02Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DRMADermata Therapeutics Inc
07/07/202321:21Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:DRMADermata Therapeutics Inc
23/06/202321:29Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:DRMADermata Therapeutics Inc
23/06/202321:19Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:DRMADermata Therapeutics Inc
12/06/202322:28Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:DRMADermata Therapeutics Inc
24/05/202322:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DRMADermata Therapeutics Inc
11/05/202321:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DRMADermata Therapeutics Inc
11/05/202321:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DRMADermata Therapeutics Inc
31/03/202321:11Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:DRMADermata Therapeutics Inc
30/03/202321:08Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:DRMADermata Therapeutics Inc
21/03/202310:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:DRMADermata Therapeutics Inc
20/03/202320:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DRMADermata Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:DRMA

Your Recent History

LSE
OXB
Oxford Biomedica
LSE
RKH
Rockhopper Exploration
LSE
GDR
Genedrive
LSE
DELT
Deltic Energy
LSE
GOLD
LSE
HCM
Hutchmed (china)
LSE
CLA
Celsius Resources
LSE
FME
Future Metals Nl
LSE
BARC
Barclays
LSE
TEN
LSE
BLOE
Block Energy
LSE
JLP
Jubilee Metals
LSE
EEE
Empire Metals
LSE
API
Abrdn Property Income
LSE
GKP
Gulf Keystone Petroleum
LSE
EMG
Man
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved